- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 487/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 487/14
Total number of patents in this class: 1486
10-year publication summary
|
104
|
108
|
97
|
110
|
119
|
124
|
120
|
142
|
130
|
42
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Abbvie Inc. | 1808 |
59 |
| G1 Therapeutics, Inc. | 128 |
56 |
| Intra-Cellular Therapies, Inc. | 378 |
39 |
| Merck Patent GmbH | 5909 |
30 |
| Agenebio, Inc. | 41 |
27 |
| Novartis AG | 11238 |
26 |
| Idemitsu Kosan Co., Ltd. | 3995 |
25 |
| Bristol-myers Squibb Company | 5080 |
24 |
| Achillion Pharmaceuticals, Inc. | 176 |
23 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
21 |
| Bayer Pharma AG | 1096 |
18 |
| Genentech, Inc. | 3742 |
17 |
| Duk San Neolux Co., Ltd. | 512 |
15 |
| F. Hoffmann-La Roche AG | 7958 |
14 |
| Samsung Display Co., Ltd. | 30585 |
14 |
| Bayer AG | 3045 |
14 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
14 |
| Merck Sharp & Dohme LLC | 3689 |
14 |
| Siteone Therapeutics, Inc. | 16 |
13 |
| The Broad Institute, Inc. | 1584 |
12 |
| Other owners | 1011 |